Has Simon Law, MD received payments from drug or device companies?

Yes. Drug and device makers reported $112 in general payments to Simon Law, MD across 3 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Simon Law, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Simon Law, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Simon Law, MD

Ophthalmology · Los Angeles, CANPI 1417961632

Payments from drug & device makers

$112in general payments, 2019–2025

Across 3 payments — averaging $37.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sight Sciences, Inc.$79
Glaukos Corporation$32

What the payments were for

Food & beverage$112100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sight Sciences, Inc.	1	$79
Glaukos Corporation	2	$32

How this compares

$112 in reported general payments places this provider in the 10th percentile of 2,513 ophthalmology providers in California.

See all ophthalmology providers in California →

Medicare billing

Part B allowed, 2024

$717,968

Medicare patients

1,940

Services billed

6,505

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
LumiganBimatoprost	256	$135,054
Alphagan PBrimonidine Tartrate	267	$107,263
Brimonidine Tartrate	671	$66,912
RhopressaNetarsudil Mesylate	111	$64,862
VyzultaLatanoprostene Bunod	115	$49,942
RocklatanNetarsudil Mesylat/Latanoprost	100	$45,448
CombiganBrimonidine Tartrate/Timolol	107	$37,780
RestasisCyclosporine	21	$32,185
Brinzolamide	186	$28,655
SimbrinzaBrinzolamide/Brimonidine Tart	98	$27,037
AzoptBrinzolamide	61	$26,557
Latanoprost	1,896	$20,920
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol	141	$20,674
Dorzolamide-TimololDorzolamide/Timolol/Pf	116	$19,842
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	926	$18,645

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Los Angeles

Steven JacobsonLos Angeles$4.7M
David BoyerLos Angeles$4M
Firas RahhalLos Angeles$1.2M
Nicole FramLos Angeles$1.2M
Andrew MoshfeghiLos Angeles$1M
Pradeep PrasadLos Angeles$901K
Barry SeibelLos Angeles$835K
David LiaoLos Angeles$722K
Nisha AcharyaSan Francisco$33M
David WirtaNewport Beach$18.4M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →